NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
NRNP 6675 MIDTERM EXAM (YEAR 2024 – 100/100
POINTS) LATEST UPDATE
1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all
that apply Age
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing
which of the following effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS) Causes prolactinemia
Reduces positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects by blocking
which of the following receptors?
GABA type
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 1/59
, NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
Serotonin
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 2/59
, NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
Dopamine receptors
NMDA type receptors
4. The diagnosis used to describe a syndrome characterized by specific signs and
symptoms resulting from recent ingestion or exposure to a substance is known as which
of the following?
Substance
intoxication
Substance
withdrawal
Substance use
disorder Any of the
above
fi. Abnormal involuntary movements in a rhythmic pattern affecting face, mouth, tongue,
jaw is known as which of the following?
Akathisi
a
Dystoni
a
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 3/59
, NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
Tardive dyskinesia
Extrapyramidal side
effects
6. A deeply held belief despite evidence to the contrary, lasting at least one month, without
prominent hallucinations, with functional impairment that relates to the delusional syste.....
Schizophrenia
Delusional disorder
Brief psychotic
disorder
Schizophreniform disorder
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 4/59
(LATEST-2023/2024, 100 Q & A)
NRNP 6675 MIDTERM EXAM (YEAR 2024 – 100/100
POINTS) LATEST UPDATE
1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all
that apply Age
Rapid dose escalation
Parental route of administration
Higher potency typical antipsychotics
2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing
which of the following effects?
Reduces negative symptoms
Increases extra pyramidal symptoms
(EPS) Causes prolactinemia
Reduces positive symptoms
3. Phencyclidine (PCP) and Ketamine exert their unique behavioral effects by blocking
which of the following receptors?
GABA type
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 1/59
, NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
Serotonin
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 2/59
, NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
Dopamine receptors
NMDA type receptors
4. The diagnosis used to describe a syndrome characterized by specific signs and
symptoms resulting from recent ingestion or exposure to a substance is known as which
of the following?
Substance
intoxication
Substance
withdrawal
Substance use
disorder Any of the
above
fi. Abnormal involuntary movements in a rhythmic pattern affecting face, mouth, tongue,
jaw is known as which of the following?
Akathisi
a
Dystoni
a
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 3/59
, NRNP 6675 MIDTERM EXAM
(LATEST-2023/2024, 100 Q & A)
Tardive dyskinesia
Extrapyramidal side
effects
6. A deeply held belief despite evidence to the contrary, lasting at least one month, without
prominent hallucinations, with functional impairment that relates to the delusional syste.....
Schizophrenia
Delusional disorder
Brief psychotic
disorder
Schizophreniform disorder
NRNP 6675 MIDTERM EXAM (YEAR 2022 – 100/100
POINTS) LATEST UPDATE
about:blank 4/59
